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A 35-year-old woman presented to the emergency room for the evaluation of failed surgical and medical management of a
suspectedectopicpregnancy.Whenimagingstudieswereperformed,shehadlymphadenopathyanddiﬀusesclerosisoftheosseous
framework. Multiple biopsies were performed and revealed poorly diﬀerentiated metastatic carcinoma with signet ring features.
Esophagogastroduodenoscopy conﬁrmed the ﬁndings of a Stage IV gastric adenocarcinoma. Signs and symptoms of gastric
carcinoma are vague. However, to our knowledge, an elevation in human chorionic gonadotropin (hCG) is not an associated
ﬁnding. Persistence of hCG has many causes from abnormal pregnancy to menopause and other forms of cancer.
1.Introduction
Elevations in human chorionic gonadotropin (hCG) exist
in few conditions outside of pregnancy, such as chorio-
carcinoma, solid tumors, or perimenopause/menopause [1,
2]. To our knowledge, elevations of hCG have not been
associated with gastric adenocarcinoma. The incidence of
gastric carcinoma is decreasing worldwide and in the United
States. African-Americans, Hispanics, and Native Americans
are twice as likely to develop gastric cancer as Caucasians.
Etiology remains unknown; however, risks include perni-
cious anemia, H. pylori infection, and/or tobacco usage.
Signs/symptoms are nonspeciﬁc until advanced disease [3].
We report a case of a 35-year-old female diagnosed
with gastric carcinoma in the setting of persistently elevated
hCG. She had no evidence of a pregnancy, either normal or
abnormal. When imaging studies were performed, she had
lymphadenopathy which was biopsied to reveal gastric car-
cinoma with signet ring cells. Esophagogastroduodenoscopy
conﬁrmed the ﬁndings, and the patient began chemotherapy
for Stage IV gastric carcinoma and no pathological evi-
dence of choriocarcinoma or germ cell component to her
tumor. Both urine and serum hCG became negative after
chemotherapy.
2. Report of a Case
The patient is a 35-year old G4P2012 with a last menstrual
period of December 18, 2010 who presented to the emer-
gency room for the evaluation of failed surgical and medical
management of a suspected ectopic pregnancy. Approxi-
mately 4–6 weeks prior to emergency room visit, patient
was treated with methotrexate for asymptomatic ectopic
pregnancy with a beta-human chorionic gonadotropin (β-
hCG) of 54 (0–5MIU/mL). After an inappropriate response
to medical therapy, a persistent β-hCG of 53, she continued
to have intermittent bleeding and anemia, for which she
receivedtwounitsofpackedredbloodcells.Aftercounseling,
patient agreed to proceed with laparoscopy and dilation
and curettage (D&C). At the time of surgery, there was no
evidence of an ectopic pregnancy, and abdominal anatomy
appeared grossly normal. The pathology from the D&C
showed proliferative endometrium.
While in the emergency room, the patient’s only
complaint was bilateral hip pain since her surgery. She
denied abdominal pain, vaginal bleeding, nausea, vomiting,
or any other symptoms. During evaluation, patient was
febrile (temp 101.5), dyspnea, and tachycardiac (120bpm).
Her laboratory values were signiﬁcant for severe anemia2 Case Reports in Obstetrics and Gynecology
Figure 1: Retroperitoneal lymph node biopsy stained with hema-
toxylin and eosin (H&E) at 25x magniﬁcation showing poorly
diﬀerentiated carcinoma with signet ring cells.
with a hemoglobin/hematocrit of 6.6/29 (hemoglobin: 12–
16gm/dL and hematocrit: 30–48%), alkaline phosphatase of
856IU/L (38–126), lactate dehydrogenase (LDH) of 959IU
(91–200), and a β-hcg of 63 with negative heterophilic
antibodies and a positive urine hCG. She underwent a pelvic
ultrasound for suspected gestational trophoblastic disease
which was normal with an endometrial thickness of 5.8mm.
Further evaluation with a computed tomography (CT) scan
of the abdomen and pelvis was signiﬁcant for retroperitoneal
adenopathy along with diﬀuse sclerosis within the osseous
framework. Magnetic resonance imaging (MRI) of spine
and bone scan conﬁrmed metastatic malignancy to bony
structures of the humorous, ribs, spine, and femur.
During her hospitalization, she had biopsy of her lymph
node, bone marrow and an esophagogastroduodenoscopy
(EGD). All of which were positive for gastric carcinoma with
signet ring features as shown in Figures 1–6. As shown in
Figures 1 and 2 from her retroperitoneal lymph node biopsy,
which were stained with hematoxylin and eosin (H&E) at
magniﬁcations of 25x and 400x, respectively, demonstrated
poorly diﬀerentiated metastatic carcinoma with signet ring
cells. Biopsy from her bone marrow (Figures 3 and 4)w a s
consistent with the biopsy from her lymph nodes. Stage
IV gastric carcinoma (Figures 5 and 6)w a sc o n ﬁ r m e db y
a biopsy of the lesser curvature of the stomach, which
demonstrated poorly diﬀerentiated carcinoma with signet
ring cells. This patient’s physical examination and medical
history were unremarkable. She is not a smoker and has no
family history of cancer. This patient is currently receiving
chemotherapy for Stage IV gastric carcinoma, and her hCG,
both urine and serum, has become negative with treatment.
3. Discussion
The incidence of gastric cancer has been decreasing world-
wide and in the United States. However, in Asia and
Eastern Europe, gastric cancer remains the leading cause of
cancer death. In the U.S., the average age of occurrence is
70yrs of age with African-Americans, Hispanics, and Native
Figure 2: Retroperitoneal lymph node biopsy stained with H&E at
400x magniﬁcation showing poorly diﬀerentiated carcinoma with
signet ring cells.
Americans are twice more likely to develop gastric cancer
than Caucasians. Rarely, does this cancer occur before the
age of forty. Survival is related to tumor stage, location,
and histological features. Twenty percent of gastric cancer
is localized. The over-all long-term survival rate is less than
15% [3].
The etiology of this disease remains unknown; however,
risks for the disease include pernicious anemia, family
history,H.pyloriinfection,tobaccousage,andbloodgroupA
[4]. The most common neoplasm is adenocarcinoma, which
is found in 95% of patients with gastric cancer diagnosis,
with the remaining 5% being carcinoid, lymphoma, squa-
mous cell carcinoma, and sarcoma [3]. Tumor grade and
histology are important prognostic indicators of this disease.
There are several histological classiﬁcations, and using
the Lauren classiﬁcation, intestinal which is 53%; diﬀuse,
33%; unclassiﬁed, 14%. Intestinal is usually associated with
chronic gastritis, dysplasia, and intestinal metaplasia and is
less aggressive. Accounting for approximately 70% of cases
and occurs in men and the elderly, with a mean age of 63,
the diﬀuse type usually occurs more commonly in younger
patients and carries a poorer prognosis [3–5].
Signs and symptoms are usually nonspeciﬁc until
advanced disease. Patients can complain of dyspepsia,
anorexia, and weight loss, early satiety to acute upper
gastrointestinal bleeding with hematemesis or melena. Phys-
ical examination is rarely helpful because gastric mass is
palpate in <20% of cases. Signs of metastatic spread include
left supraclavicular lymph node (Virchow node), umbilical
nodule (Sister Mary Joseph nodule), ovarian metastases
(krukenberg tumor), or rigid rectal shelf (Blumer shelf)
[4, 6].
Discovered in 1912 by Bernhard Aschner, hCG is the
hormone that maintains progesterone production in early
pregnancy. It has many roles during pregnancy, such as
signaling the uterus to prepare for implantation. Produced
by the syncytiotrophoblast cells, it promotes adequate blood
supply to the placenta during pregnancy. Elevations inCase Reports in Obstetrics and Gynecology 3
Figure 3: Bone marrow biopsy showing poorly diﬀerentiated
carcinoma with signet ring cells at 25x magniﬁcation and stained
with H&E.
Figure 4: Bone marrow biopsy showing poorly diﬀerentiated
carcinoma with signet ring cells at 400x magniﬁcation and stained
with H&E.
human chorionic gonadotropin (hCG) exist in a few condi-
tions outside of pregnancy, such as gestational trophoblas-
tic disease (GTD) or choriocarcinoma, solid tumors, or
perimenopause/menopause. There are three forms of hCG:
hyperglycosylated hCG, free β-hCG, and pituitary hCG [1].
Hyperglycosylated hCG, which is made by cytotro-
phoblastcells,stimulatesimplantationandgrowthofthepla-
centa by promoting invasion and growth of these (cytotro-
phoblast) cells. Because it stimulates growth and invasion
by gestational trophoblastic neoplasms, invasive moles, and
choriocarcinomas, it is present in these diseases. Free β-
hCG is produced by all advanced cancer primaries, such as
germ cell tumors, teratomas, leiomyosarcomas, lymphomas,
or leukemia. This form of hCG (free) promotes cell invasion
and malignancy. Pituitary hCG is naturally produced at
extremely low levels during the menstrual cycle. In the
perimenopausal and menopausal state, levels of pituitary
hCG increase because of the absence of circulating estradiol
a n dp r o g e s t e r o n el e v e l s[ 1, 2].
Figure 5: Lesser curvature of the stomach stained with H&E at 25x
magniﬁcation showing poorly diﬀerentiated carcinoma with signet
ring cells.
Figure 6: Lesser curvature of the stomach with H&E staining at
400x magniﬁcation shows poorly diﬀerentiated carcinoma with
signet ring cells.
In reproductive aged women with elevated hCG, preg-
nancy, either normal or abnormal (i.e., missed abortion,
ectopic pregnancy, etc.) should be ruled out. Outside of
that, malignancy should be ruled out with imaging and
bloodtests.Toourknowledge,gastricadenocarcinomaisnot
associated with hCG. It is an insidious disease with vague
signs and symptoms.
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